Загрузка...
Ligand binding mode prediction by docking: Mdm2/Mdmx inhibitors as a case study
The p53-binding domains of Mdm2 and Mdmx, two negative regulators of the tumor suppressor, p53, are validated targets for cancer therapeutics, but correct binding poses of some proven inhibitors, particularly the nutlins, have been difficult to obtain with standard docking procedures. Virtual screen...
Сохранить в:
| Опубликовано в: : | J Chem Inf Model |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4753531/ https://ncbi.nlm.nih.gov/pubmed/24358984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ci4004656 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|